Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 15.64
(0.77%)
CNY 15.64
(0.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 265.07 Million CNY | -9.52% |
| 2022 | 576.84 Million CNY | -2.53% |
| 2021 | 591.84 Million CNY | -7.99% |
| 2020 | 643.25 Million CNY | -33.79% |
| 2019 | 971.52 Million CNY | 7.57% |
| 2018 | 903.13 Million CNY | 63.5% |
| 2017 | 552.36 Million CNY | 50.83% |
| 2016 | 366.2 Million CNY | 22.13% |
| 2015 | 299.83 Million CNY | -11.38% |
| 2014 | 338.34 Million CNY | -8.6% |
| 2013 | 370.16 Million CNY | 0.93% |
| 2012 | 366.77 Million CNY | 65.02% |
| 2011 | 222.25 Million CNY | 11.33% |
| 2010 | 199.64 Million CNY | 20.68% |
| 2009 | 165.43 Million CNY | 1.65% |
| 2008 | 162.74 Million CNY | 37.37% |
| 2007 | 118.47 Million CNY | -13.22% |
| 2006 | 136.52 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 148.52 Million CNY | 13.85% |
| 2024 Q2 | 172.98 Million CNY | 16.46% |
| 2024 Q3 | 139.62 Million CNY | -61.6% |
| 2023 Q4 | 130.45 Million CNY | 16.72% |
| 2023 FY | 521.91 Million CNY | -9.52% |
| 2023 Q1 | 157.55 Million CNY | 38.15% |
| 2023 Q2 | 173.96 Million CNY | 10.41% |
| 2023 Q3 | 111.77 Million CNY | -35.75% |
| 2022 Q1 | 141.73 Million CNY | -9.71% |
| 2022 FY | 576.84 Million CNY | -2.53% |
| 2022 Q4 | 114.04 Million CNY | -23.98% |
| 2022 Q3 | 150.01 Million CNY | -12.3% |
| 2022 Q2 | 171.05 Million CNY | 20.69% |
| 2021 Q1 | 156.12 Million CNY | 21.6% |
| 2021 Q2 | 145.57 Million CNY | -6.76% |
| 2021 Q3 | 133.17 Million CNY | -8.51% |
| 2021 Q4 | 156.97 Million CNY | 17.87% |
| 2021 FY | 591.84 Million CNY | -7.99% |
| 2020 Q1 | 189.84 Million CNY | -20.13% |
| 2020 Q2 | 157.85 Million CNY | -16.85% |
| 2020 Q3 | 167.15 Million CNY | 5.89% |
| 2020 Q4 | 128.39 Million CNY | -23.19% |
| 2020 FY | 643.25 Million CNY | -33.79% |
| 2019 Q4 | 237.69 Million CNY | 8.85% |
| 2019 Q1 | 251.57 Million CNY | 14.16% |
| 2019 FY | 971.52 Million CNY | 7.57% |
| 2019 Q3 | 218.36 Million CNY | -17.25% |
| 2019 Q2 | 263.89 Million CNY | 4.9% |
| 2018 Q4 | 220.36 Million CNY | 1.27% |
| 2018 FY | 903.13 Million CNY | 63.5% |
| 2018 Q3 | 217.61 Million CNY | -8.59% |
| 2018 Q2 | 238.05 Million CNY | 4.83% |
| 2018 Q1 | 227.09 Million CNY | 17.82% |
| 2017 FY | 552.36 Million CNY | 50.83% |
| 2017 Q1 | 120.4 Million CNY | 20.32% |
| 2017 Q3 | 132.28 Million CNY | 23.71% |
| 2017 Q4 | 192.73 Million CNY | 45.7% |
| 2017 Q2 | 106.93 Million CNY | -11.18% |
| 2016 FY | 366.2 Million CNY | 22.13% |
| 2016 Q1 | 82.67 Million CNY | 16.75% |
| 2016 Q3 | 85.81 Million CNY | -12.11% |
| 2016 Q2 | 97.64 Million CNY | 18.1% |
| 2016 Q4 | 100.07 Million CNY | 16.61% |
| 2015 FY | 299.83 Million CNY | -11.38% |
| 2015 Q2 | 88.21 Million CNY | 12.08% |
| 2015 Q3 | 62.1 Million CNY | -29.6% |
| 2015 Q4 | 70.81 Million CNY | 14.04% |
| 2015 Q1 | 78.7 Million CNY | -9.9% |
| 2014 Q2 | 81.52 Million CNY | -20.4% |
| 2014 Q4 | 87.35 Million CNY | 30.25% |
| 2014 Q3 | 67.06 Million CNY | -17.74% |
| 2014 Q1 | 102.4 Million CNY | 0.72% |
| 2014 FY | 338.34 Million CNY | -8.6% |
| 2013 Q3 | 76.19 Million CNY | -27.27% |
| 2013 Q2 | 104.75 Million CNY | 19.66% |
| 2013 FY | 370.16 Million CNY | 0.93% |
| 2013 Q4 | 101.67 Million CNY | 33.45% |
| 2013 Q1 | 87.54 Million CNY | -27.39% |
| 2012 Q1 | 53.95 Million CNY | -28.84% |
| 2012 Q4 | 120.57 Million CNY | 47.65% |
| 2012 Q3 | 81.66 Million CNY | -26.16% |
| 2012 Q2 | 110.58 Million CNY | 104.95% |
| 2012 FY | 366.77 Million CNY | 65.02% |
| 2011 Q2 | 42.82 Million CNY | -31.47% |
| 2011 Q1 | 62.49 Million CNY | -3.24% |
| 2011 Q4 | 75.82 Million CNY | 84.39% |
| 2011 FY | 222.25 Million CNY | 11.33% |
| 2011 Q3 | 41.11 Million CNY | -3.98% |
| 2010 Q2 | 37.93 Million CNY | -32.09% |
| 2010 FY | 199.64 Million CNY | 20.68% |
| 2010 Q3 | 41.24 Million CNY | 8.72% |
| 2010 Q4 | 64.58 Million CNY | 56.59% |
| 2010 Q1 | 55.86 Million CNY | 34.8% |
| 2009 Q4 | 41.44 Million CNY | -1.59% |
| 2009 Q1 | 41.55 Million CNY | 0.0% |
| 2009 Q2 | 40.31 Million CNY | -2.96% |
| 2009 FY | 165.43 Million CNY | 1.65% |
| 2009 Q3 | 42.11 Million CNY | 4.46% |
| 2008 FY | 162.74 Million CNY | 37.37% |
| 2007 FY | 118.47 Million CNY | -13.22% |
| 2006 FY | 136.52 Million CNY | 0.0% |